Medical Devices | Stent Lawsuits

Boston Scientific Taxus Stent News

Boston Scientific Stent Best in Study

RSS News Feeds
Medical Device Defects
Boston Scientific Taxus Stent
 All RSS Feeds

At a glance:

Boston Scientific Corp. states that statistics from the multi-center STENT registry show that patients with its TAXUS Express2 paclitaxel-eluting stent system have better outcomes than patients with Johnson & Johnson's Cypher sirolimus-eluting stent system. 
 
The study was comprised of over 5000 patients who received one of the two stents at eight different hospitals.

Boston Scientific Says Data Reinforces Benefits Of TAXUS Stents In ...

Trading Markets - 6/12/2006 12:59 PM

(RTTNews) - Boston Scientific Corp. said results from the multi-center STENT registry revealed numerically favorable outcomes for the TAXUS Express2 paclitaxel-eluting stent system compared to Johnson & Johnson's Cypher sirolimus-eluting stent system in reducing mortality rates and overall major adverse cardiovascular events.
 
The STENT registry included follow-up on 5,566 patients at eight coronary centers in the United States who received either a TAXUS stent system or a Cypher stent system.
 
· Read The Full Boston Scientific Taxus Stent Article From Trading Markets -->

· Read All Boston Scientific Taxus Stent News Stories -->

Comments On Boston Scientific Taxus Stent News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: